Drug Monitoring
Research News and Information

Saturday, November 21, 2009

High-throughput ultra-high-performance liquid chromatography/tandem mass spectrometry quantitation of insulin-like growth factor-I and leucine-rich alpha-2-glycoprotein in serum as biomarkers of recombinant human growth hormone administration.

29 Sep 2009 Insulin-like growth factor-I (IGF-I) is a known biomarker of recombinant human growth hormone (rhGH) abuse, and is also used clinically to confirm acromegaly. The protein leucine-rich alpha-2-glycoprotein (LRG) was recently identified as a putative ... Read more...

Toxicodynamics of itraconazole: implications for therapeutic drug monitoring.

13 Sep 2009 We explored concentration-toxicity relationships for itraconazole among 216 patients. Logistic regression revealed a progressive increase in the probability of toxicity with increasing concentrations of itraconazole. Classification and regression ... Read more...

Women's experiences of participating in the Magpie Trial: a postal survey in the United Kingdom.

30 Aug 2009 BACKGROUND: The Magpie Trial compared magnesium sulfate with placebo for women with preeclampsia. The objective of this study was to explore women's views and experiences of participating in the Magpie Trial in the United Kingdom. METHODS: Postal ... Read more...

Latest indexed articles for 'Drug Monitoring'

These are the very latest articles for this heading:

• Blood infection diagnosis by 16S rDNA broad-spectrum polymerase chain reaction: the relationship between antibiotic treatment and bacterial DNA load. 30 Oct 2009
• Monitoring and evaluation of PEPFAR treatment programmes. Oct 2009
• High-throughput ultra-high-performance liquid chromatography/tandem mass spectrometry quantitation of insulin-like growth factor-I and leucine-rich alpha-2-glycoprotein in serum as biomarkers of recombinant human growth hormone administration. 29 Sep 2009
• Toxicodynamics of itraconazole: implications for therapeutic drug monitoring. 13 Sep 2009
• Women's experiences of participating in the Magpie Trial: a postal survey in the United Kingdom. 30 Aug 2009
• Prevention of sternal wound infections after coronary artery bypass graft surgery with use of insulin drug therapy: a review of the literature. 30 Aug 2009
• Hospital pharmacists' activities and attitudes regarding the Thai safety monitoring program for new drugs. 30 Aug 2009
• Comparison of selected sedation scales for reporting opioid-induced sedation assessment. 30 Aug 2009
• Duloxetine serum concentrations and clinical effects. Data from a therapeutic drug monitoring (TDM) survey. 30 Aug 2009
• Drug use evaluation of sitagliptin dosing by pharmacist versus nonpharmacist clinicians in an internal medicine department of a private physician-owned multispecialty clinic. 30 Aug 2009
• Obidoxime in acute organophosphate poisoning: 2 - PK/PD relationships. 30 Aug 2009
• The revival of clinical wisdom: The case of oral anticoagulation management. 30 Aug 2009
• A checklist approach to selecting the optimal treatment regimen for a patient with type 2 diabetes. 30 Aug 2009
• Hypoglycemia and intensive insulin therapy: strict vigilance and prompt correction. 30 Aug 2009
• Use of a new antiepileptic drug or an old one as first drug for treatment of absence epilepsy. 30 Aug 2009
• Clinical implications and management of bleeding events in patients with acute coronary syndromes. 30 Aug 2009
• Rivaroxaban versus enoxaparin after total knee arthroplasty. 27 Aug 2009
• Otamixaban in acute coronary syndromes. 26 Aug 2009
• Monitoring ocular drug therapy by analysis of aqueous samples. 20 Aug 2009
• Compliance with platelet count monitoring recommendations and management of possible heparin-induced thrombocytopenia in hospitalized patients receiving low-molecular-weight heparin. 16 Aug 2009

See a longer list of these articles.

Technical information about 'Drug Monitoring'

Definition: The process of observing, recording, or detecting the effects of a chemical substance administered to an individual therapeutically or diagnostically.

Descriptor UI: D016903

Alternative terms: Drug Monitoring; Monitoring, Drug; Therapeutic Drug Monitoring; Drug Monitoring, Therapeutic; Monitoring, Therapeutic Drug;

Related Mesh Headings: Adverse Drug Reaction Reporting Systems;

Allowable Qualifiers: adverse effects; classification; economics; history; instrumentation; methods; mortality; nursing; psychology; standards; trends; utilization; veterinary; statistics & numerical data; contraindications; ethics;

Tree Number: E01.370.520.200;

History Note: 92